Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood donors

Transfusion

Volumn 44, Issue 7, 2004, Pages 1059-1066

  Rahbar, Afsar R ^a   Sundqvist, V A S ^b   Zweygberg Wirgart, B ^b   Grillner, L ^b   Soderberg Naucler C ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; VIRUS INFECTION; VIRUS ISOLATION; VIRUS TRANSMISSION; WESTERN BLOTTING;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOOD DONORS; BLOTTING, WESTERN; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G;

EID: 3042634922     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.03292.x     Document Type: Article

References (29)

1. Jordan MC. Latent infection and the elusive cytomegalovirus. Rev Infect Dis 1983;5:2025-215.
2. Ballard RA, Drew WL, Hufnagle KG, et al. Acquired cytomegalovirus infection in preterm infants. Am J Dis Child 1979;133:482-5.
3. Yeager AS, Grumet FC, Hafleigh EB, et al. Prevention of transfusion-acquired cytome-galovirus infection in newborn infants. J Pediatr 1981;98:281-7.
4. Adler SP, Chandrika T, Lawrence L, et al. Cytomegalovirus infections in neonates acquired by blood transfusion. Pediatr Infect Dis 1983;2:114-8.
5. Bowden RA, Sayers M, Flournoy N, et al. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomega-lovirus infection after marrow transplantation. N Engl J Med 1986;314:1006-10.
6. Gilbet GL, Hayers K, Hudson IL, et al. Prevention of transfusion-acquired cytome-galovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group Lancet 1989;1(8649): 1228-31.
7. Miller WJ, McCullough J, Balfour HH Jr, et al. Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood products screening. Bone Marrow Transplant 1991;7:227-34.
8. Hillyer CD, Emmens RK, Zago-Novaretti M, et al. Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor units. Transfusion 1994;34:929-34.
9. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the preventation of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598-603.
10. Ljungman P, Larsson K, Kumlien G, et al. Leukocyte depleted, unscreened blood products give a low risk for CMV infection and disease in CMV sronegative allogenic stem cell transplant recipients with seronegative stem cell donors. Scand J Infect Dis 2002;34:347-50.
11. Meyers H, Bankier AT, Landini MP, et al. Identification and procaryotic expression of the gene coding for the highly immunogenic 28-kilodalton structural phosphoprotein (pp28) of human cytomegalo-virus. J Virol 1988;62:2243-50.
12. Larsson S, Soderberg-Naucler C, Wang FZ, et al. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion 1998;38:271-8.
13. Rahbar A, Bostrom L, Lagerstedt U, et al. Evidence of active cytomegalovirus infection in intestinal tissue sections from patients with inflammatory bowel disease. Inflammatory Bowel Dis 2003;9:154-61.
14. Roback JD, Hillyer CD, Drew WL, et al. Multicenter evaluation of PCR methods for detecting cytomegalovirus (CMV) DNA in blood donors. Transfusion 2001;41:1249-57.
15. Grillner L. Screening of blood donors for cytomegalovirus (CMV) antibodies: an evaluation of different tests. J Virol Methods 1987;17:133-9.
16. Cha TA, Tom E, Kemble GW, et al. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 1996;70:78-83.
17. Schmitz H, Doerr HW, Kampa D, et al. Solid-phase enzyme immunoassay for immunoglobulin M antibodies to cytomegalovirus. J Clin Microbiol 1977;5:629-34.
18. Sundqvist VA, Wahren B, et al. Development of sensitive and enzyme-linked immunoassays for herpesvirus antigens and some applications. Dev Biol Stand 1982;52:245-53.
19. Scholl BC, Von Hintzenstem J, Borisch B, et al. Procaryptic expression of immunogenic polypeptides of the large phosphoprotein (pp150) of human cytomegalovirus. J Gen Virol 1988;69:1195-1204.
20. Ripalti A, Landini MP, Mocarski ES, et al. Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection. J Clin Microbiol 1989;27:2324-7.
21. Ripalti A, Landini MP, Mocarski ES, et al. Identification and preliminary use of recom-binant lambda gt11 fusion proteins in cytomegalovirus diag-nosis. J Gen Virol 1989;70:1247-51.
22. Platcher B, Wieczorek L, Scholl BC, et al. Detection of cytomegalovirus antibodies by enzyme-linked immunosorbent assay using recombinant polypeptides of the large phosphorylated tegument protein pp150. J Clin Microbiol 1992;30:201-6.
23. Vornhagen R, Hinderer W, Sonneborn HH, et al. The DNA-binding protein pUL57 of human cytomegalovirus is a major target antigen for the immunoglobulin M antibody response during acute infec-tion. J Clin Microbiol 1995;33:1927-30.
24. Doerr HW, et al. New developments in CMV antibody screening. Biotest Bull 1990;4:124-30.
25. Meyers JD, Flournoy N, Thomas ED, et al. Risk factors for cytomegalovirus infection after human marrow transplantation 1986;153:478-88.
26. Söderberg-Naucler C, Fish KN, Nelson JA, et al. Reactivation of latent human cytomegalovirus by allogenic stimulation of blood cells from healthy donors. Cell 1997;3:91:119-26.
27. Hebert H, Einsele H, Klein R, et al. CMV infection after allogeneic bone marrow transplantation is associated with the occurrence of various autoantibodies and monoclonal gammopaties. Br Haematol 1996;95:138-44.
28. Varani S, Muratori L, De Ruvo N, et al. Autoantibody appearance in cytomegalo-virus-infected liver transplant recipients: correlation with antigenemia. J Med Virol 2002;66:56-62.
29. Britt WJ, Alford CA. Cytomegalovirus. In: Fields BN, Knipe DM, Howley PM, et al., eds. Virology. New York: Raven Press, 1996.